Comment on Fust et al. The Potential Economic Impact of the Updated COVID-19 mRNA Fall 2023 Vaccines in Japan. Vaccines 2024, 12, 434

Vaccines (Basel). 2024 Oct 17;12(10):1174. doi: 10.3390/vaccines12101174.

Abstract

We noted three key inconsistencies in the Moderna-funded cost-effectiveness analysis by Fust et al [...].

Keywords: COVID-19; Japan; SARS-CoV-2; coronavirus; cost-effectiveness; vaccination.

Grants and funding